Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy

NCT06956014 is registered in ClinicalTrials.gov with Vertanical GmbH as lead sponsor.

NCT NCT06956014
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06956014 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy
Lead sponsor
Vertanical GmbH
Phase
Phase 3
Overall status
Recruiting
Start date
September 22, 2026
Completion date
September 30, 2028
Enrollment
810 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lumbosacral radiculopathy